| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| UCB.BR - UCB SA | BUY | 344 @ EUR 309.671 | EUR 106,527 | The ETF bought 344 new shares of UCB.BR (UCB SA). The shares were bought for an average price of 309.671 compared to the previous average buy price of 226.575. This is 36.7% higher than average price of previous purchases of UCB.BR. |
| EXAS - EXACT Sciences Corporation | BUY | 993 @ USD 103.18 | USD 102,458 | The ETF bought 993 new shares of EXAS (EXACT Sciences Corporation). The shares were bought for an average price of 103.18 compared to the previous average buy price of 70.5974. This is 46.2% higher than average price of previous purchases of EXAS. |
| JNJ - Johnson & Johnson | BUY | 413 @ USD 239.99 | USD 99,116 | The ETF bought 413 new shares of JNJ (Johnson & Johnson). The shares were bought for an average price of 239.99 compared to the previous average buy price of 182.297. This is 31.6% higher than average price of previous purchases of JNJ. |
| MRK - Marks Electrical Group PLC | BUY | 795 @ USD 121.93 | USD 96,934 | The ETF bought 795 new shares of MRK (Marks Electrical Group PLC). The shares were bought for an average price of 121.93 compared to the previous average buy price of 82.3939. This is 48.0% higher than average price of previous purchases of MRK. |
| MRK - Merck & Company Inc | BUY | 795 @ USD 121.93 | USD 96,934 | The ETF bought 795 new shares of MRK (Merck & Company Inc). The shares were bought for an average price of 121.93 compared to the previous average buy price of 82.3939. This is 48.0% higher than average price of previous purchases of MRK. |
| BIIB - Biogen Inc | BUY | 477 @ USD 201.18 | USD 95,963 | The ETF bought 477 new shares of BIIB (Biogen Inc). The shares were bought for an average price of 201.18 compared to the previous average buy price of 133.158. This is 51.1% higher than average price of previous purchases of BIIB. |
| GSK.L - GlaxoSmithKline PLC | BUY | 3,175 @ GBP 29.9236 | GBP 95,007 | The ETF bought 3175 new shares of GSK.L (GlaxoSmithKline PLC). The shares were bought for an average price of 29.9236 compared to the previous average buy price of 20.3485. This is 47.1% higher than average price of previous purchases of GSK.L. |
| GILD - Guild Esports Plc | BUY | 588 @ USD 152.5 | USD 89,670 | The ETF bought 588 new shares of GILD (Guild Esports Plc). The shares were bought for an average price of 152.5 compared to the previous average buy price of 111.127. This is 37.2% higher than average price of previous purchases of GILD. |
| ILMN - Illumina Inc | BUY | 735 @ USD 119.72 | USD 87,994 | The ETF bought 735 new shares of ILMN (Illumina Inc). The shares were bought for an average price of 119.72 compared to the previous average buy price of 99.2305. This is 20.6% higher than average price of previous purchases of ILMN. |
| GMAB.CO - | BUY | 282 @ DKK 309.876 | DKK 87,385 | The ETF bought 282 new shares of GMAB.CO (). The shares were bought for an average price of 309.876 compared to the previous average buy price of 232.387. This is 33.3% higher than average price of previous purchases of GMAB.CO. |
| ROG.SW - | BUY | 189 @ CHF 459.723 | CHF 86,888 | The ETF bought 189 new shares of ROG.SW (). The shares were bought for an average price of 459.723 compared to the previous average buy price of 347.97. This is 32.1% higher than average price of previous purchases of ROG.SW. |
| TMO - Time Out Group plc | BUY | 156 @ USD 542.83 | USD 84,681 | The ETF bought 156 new shares of TMO (Time Out Group plc). The shares were bought for an average price of 542.83 compared to the previous average buy price of 432.097. This is 25.6% higher than average price of previous purchases of TMO. |
| AMGN - Amgen Inc | BUY | 220 @ USD 384.32 | USD 84,550 | The ETF bought 220 new shares of AMGN (Amgen Inc). The shares were bought for an average price of 384.32 compared to the previous average buy price of 303.143. This is 26.8% higher than average price of previous purchases of AMGN. |
| MRNA - Moderna Inc | BUY | 2,035 @ USD 41.01 | USD 83,455 | The ETF bought 2035 new shares of MRNA (Moderna Inc). The shares were bought for an average price of 41.01 compared to the previous average buy price of 26.3228. This is 55.8% higher than average price of previous purchases of MRNA. |
| 068270.KS - CELLTRION INC | BUY | 544 @ KRW 149.716 | KRW 81,446 | The ETF bought 544 new shares of 068270.KS (CELLTRION INC). The shares were bought for an average price of 149.716 compared to the previous average buy price of 123.544. This is 21.2% higher than average price of previous purchases of 068270.KS. |
| BMY - Bloomsbury Publishing Plc | BUY | 1,295 @ USD 61.99 | USD 80,277 | The ETF bought 1295 new shares of BMY (Bloomsbury Publishing Plc). The shares were bought for an average price of 61.99 compared to the previous average buy price of 53.6947. This is 15.4% higher than average price of previous purchases of BMY. |
| NTRA - Natera Inc | BUY | 392 @ USD 203.04 | USD 79,592 | The ETF bought 392 new shares of NTRA (Natera Inc). The shares were bought for an average price of 203.04 compared to the previous average buy price of 190.06. This is 6.8% higher than average price of previous purchases of NTRA. |
| ABBV - AbbVie Inc | BUY | 341 @ USD 223.43 | USD 76,190 | The ETF bought 341 new shares of ABBV (AbbVie Inc). The shares were bought for an average price of 223.43 compared to the previous average buy price of 208.051. This is 7.4% higher than average price of previous purchases of ABBV. |
| IQV - IQVIA Holdings Inc | BUY | 405 @ USD 187.49 | USD 75,933 | The ETF bought 405 new shares of IQV (IQVIA Holdings Inc). The shares were bought for an average price of 187.49 compared to the previous average buy price of 167.812. This is 11.7% higher than average price of previous purchases of IQV. |
| MDT - Medtronic PLC | BUY | 736 @ USD 102.9 | USD 75,734 | The ETF bought 736 new shares of MDT (Medtronic PLC). The shares were bought for an average price of 102.9 compared to the previous average buy price of 92.2389. This is 11.6% higher than average price of previous purchases of MDT. |
| HOLX - Hologic Inc | BUY | 994 @ USD 74.81 | USD 74,361 | The ETF bought 994 new shares of HOLX (Hologic Inc). The shares were bought for an average price of 74.81 compared to the previous average buy price of 67.2756. This is 11.2% higher than average price of previous purchases of HOLX. |
| NBIX - Neurocrine Biosciences Inc | BUY | 519 @ USD 141.2 | USD 73,283 | The ETF bought 519 new shares of NBIX (Neurocrine Biosciences Inc). The shares were bought for an average price of 141.2 compared to the previous average buy price of 129.339. This is 9.2% higher than average price of previous purchases of NBIX. |
| PFE - Pfizer Inc | BUY | 2,664 @ USD 27.22 | USD 72,514 | The ETF bought 2664 new shares of PFE (Pfizer Inc). The shares were bought for an average price of 27.22 compared to the previous average buy price of 24.4485. This is 11.3% higher than average price of previous purchases of PFE. |
| A - Agilent Technologies Inc | BUY | 537 @ USD 129.58 | USD 69,584 | The ETF bought 537 new shares of A (Agilent Technologies Inc). The shares were bought for an average price of 129.58 compared to the previous average buy price of 124.545. This is 4.0% higher than average price of previous purchases of A. |
| DHR - Danaher Corporation | BUY | 319 @ USD 216.61 | USD 69,099 | The ETF bought 319 new shares of DHR (Danaher Corporation). The shares were bought for an average price of 216.61 compared to the previous average buy price of 202.721. This is 6.9% higher than average price of previous purchases of DHR. |
| DHR - Danaher Corporation | BUY | 319 @ USD 216.61 | USD 69,099 | The ETF bought 319 new shares of DHR (Danaher Corporation). The shares were bought for an average price of 216.61 compared to the previous average buy price of 202.721. This is 6.9% higher than average price of previous purchases of DHR. |
| MEDP - Medpace Holdings Inc | BUY | 126 @ USD 542.04 | USD 68,297 | The ETF bought 126 new shares of MEDP (Medpace Holdings Inc). The shares were bought for an average price of 542.04 compared to the previous average buy price of 424.793. This is 27.6% higher than average price of previous purchases of MEDP. |
| EW - Edwards Lifesciences Corp | BUY | 854 @ USD 78.71 | USD 67,218 | The ETF bought 854 new shares of EW (Edwards Lifesciences Corp). The shares were bought for an average price of 78.71 compared to the previous average buy price of 75.6991. This is 4.0% higher than average price of previous purchases of EW. |
| GH - Guardant Health Inc | BUY | 652 @ USD 101.85 | USD 66,406 | The ETF bought 652 new shares of GH (Guardant Health Inc). The shares were bought for an average price of 101.85 compared to the previous average buy price of 67.3123. This is 51.3% higher than average price of previous purchases of GH. |
| EXEL - Exelixis Inc | BUY | 1,436 @ USD 43.9 | USD 63,040 | The ETF bought 1436 new shares of EXEL (Exelixis Inc). The shares were bought for an average price of 43.9 compared to the previous average buy price of 39.8111. This is 10.3% higher than average price of previous purchases of EXEL. |
| RVTY - Revvity Inc. | BUY | 620 @ USD 101.59 | USD 62,986 | The ETF bought 620 new shares of RVTY (Revvity Inc.). The shares were bought for an average price of 101.59 compared to the previous average buy price of 102.102. This is -0.5% lower than average price of previous purchases of RVTY. |
| 207940.KS - SAMSUNG BIOLOGICS LTD | BUY | 55 @ KRW 1135.12 | KRW 62,432 | The ETF bought 55 new shares of 207940.KS (SAMSUNG BIOLOGICS LTD). The shares were bought for an average price of 1135.12 compared to the previous average buy price of 846.854. This is 34.0% higher than average price of previous purchases of 207940.KS. |
| LONN.SW - | BUY | 92 @ CHF 667.14 | CHF 61,377 | The ETF bought 92 new shares of LONN.SW (). The shares were bought for an average price of 667.14 compared to the previous average buy price of 651.316. This is 2.4% higher than average price of previous purchases of LONN.SW. |
| ISRG - Intuitive Surgical Inc | BUY | 122 @ USD 488.15 | USD 59,554 | The ETF bought 122 new shares of ISRG (Intuitive Surgical Inc). The shares were bought for an average price of 488.15 compared to the previous average buy price of 541.916. This is -9.9% lower than average price of previous purchases of ISRG. |
| TECH - Bio-Techne Corp | BUY | 825 @ USD 66.78 | USD 55,094 | The ETF bought 825 new shares of TECH (Bio-Techne Corp). The shares were bought for an average price of 66.78 compared to the previous average buy price of 60.2995. This is 10.7% higher than average price of previous purchases of TECH. |
| ABT - Abbott Laboratories | BUY | 482 @ USD 110.83 | USD 53,420 | The ETF bought 482 new shares of ABT (Abbott Laboratories). The shares were bought for an average price of 110.83 compared to the previous average buy price of 124.137. This is -10.7% lower than average price of previous purchases of ABT. |
| DXCM - DexCom Inc | BUY | 763 @ USD 69.97 | USD 53,387 | The ETF bought 763 new shares of DXCM (DexCom Inc). The shares were bought for an average price of 69.97 compared to the previous average buy price of 78.1176. This is -10.4% lower than average price of previous purchases of DXCM. |
| HALO - Halozyme Therapeutics Inc | BUY | 649 @ USD 81.23 | USD 52,718 | The ETF bought 649 new shares of HALO (Halozyme Therapeutics Inc). The shares were bought for an average price of 81.23 compared to the previous average buy price of 63.1165. This is 28.7% higher than average price of previous purchases of HALO. |
| PODD - Insulet Corporation | BUY | 217 @ USD 241.93 | USD 52,499 | The ETF bought 217 new shares of PODD (Insulet Corporation). The shares were bought for an average price of 241.93 compared to the previous average buy price of 283.798. This is -14.8% lower than average price of previous purchases of PODD. |
| BSX - Boston Scientific Corporation | BUY | 652 @ USD 76.27 | USD 49,728 | The ETF bought 652 new shares of BSX (Boston Scientific Corporation). The shares were bought for an average price of 76.27 compared to the previous average buy price of 97.0625. This is -21.4% lower than average price of previous purchases of BSX. |
| BSX - MULSTRXSSXIMETFP | BUY | 652 @ USD 76.27 | USD 49,728 | The ETF bought 652 new shares of BSX (MULSTRXSSXIMETFP). The shares were bought for an average price of 76.27 compared to the previous average buy price of 97.0625. This is -21.4% lower than average price of previous purchases of BSX. |
| CRL - Creightons Plc | BUY | 258 @ USD 189.21 | USD 48,816 | The ETF bought 258 new shares of CRL (Creightons Plc). The shares were bought for an average price of 189.21 compared to the previous average buy price of 177.153. This is 6.8% higher than average price of previous purchases of CRL. |
| 4523.T - Eisai Co., Ltd. | BUY | 1,500 @ JPY 28.5742 | JPY 42,861 | The ETF bought 1500 new shares of 4523.T (Eisai Co., Ltd.). The shares were bought for an average price of 28.5742 compared to the previous average buy price of 28.6683. This is -0.3% lower than average price of previous purchases of 4523.T. |
| 7701.T - Shimadzu Corporation | BUY | 1,500 @ JPY 26.9166 | JPY 40,375 | The ETF bought 1500 new shares of 7701.T (Shimadzu Corporation). The shares were bought for an average price of 26.9166 compared to the previous average buy price of 26.618. This is 1.1% higher than average price of previous purchases of 7701.T. |
| RGEN - Repligen Corporation | BUY | 276 @ USD 142.18 | USD 39,242 | The ETF bought 276 new shares of RGEN (Repligen Corporation). The shares were bought for an average price of 142.18 compared to the previous average buy price of 150.813. This is -5.7% lower than average price of previous purchases of RGEN. |
| SRT3.DE - Sartorius AG | BUY | 133 @ EUR 283.195 | EUR 37,665 | The ETF bought 133 new shares of SRT3.DE (Sartorius AG). The shares were bought for an average price of 283.195 compared to the previous average buy price of 260.58. This is 8.7% higher than average price of previous purchases of SRT3.DE. |
| AXSM - Axsome Therapeutics Inc | BUY | 202 @ USD 182.55 | USD 36,875 | The ETF bought 202 new shares of AXSM (Axsome Therapeutics Inc). The shares were bought for an average price of 182.55 compared to the previous average buy price of 131.729. This is 38.6% higher than average price of previous purchases of AXSM. |
| PRAX - Praxis Precision Medicines Inc | BUY | 108 @ USD 319.57 | USD 34,514 | The ETF bought 108 new shares of PRAX (Praxis Precision Medicines Inc). The shares were bought for an average price of 319.57 compared to the previous average buy price of 230.084. This is 38.9% higher than average price of previous purchases of PRAX. |
| BIO - Bio-Rad Laboratories Inc | BUY | 111 @ USD 301.5 | USD 33,467 | The ETF bought 111 new shares of BIO (Bio-Rad Laboratories Inc). The shares were bought for an average price of 301.5 compared to the previous average buy price of 294.526. This is 2.4% higher than average price of previous purchases of BIO. |
| BIO - Biotest Aktiengesellschaft | BUY | 111 @ USD 301.5 | USD 33,467 | The ETF bought 111 new shares of BIO (Biotest Aktiengesellschaft). The shares were bought for an average price of 301.5 compared to the previous average buy price of 294.526. This is 2.4% higher than average price of previous purchases of BIO. |
| PME.AX - | BUY | 296 @ AUD 110.436 | AUD 32,689 | The ETF bought 296 new shares of PME.AX (). The shares were bought for an average price of 110.436 compared to the previous average buy price of 159.981. This is -31.0% lower than average price of previous purchases of PME.AX. |
| RYTM - Rhythm Pharmaceuticals Inc | BUY | 306 @ USD 103.61 | USD 31,705 | The ETF bought 306 new shares of RYTM (Rhythm Pharmaceuticals Inc). The shares were bought for an average price of 103.61 compared to the previous average buy price of 75.0313. This is 38.1% higher than average price of previous purchases of RYTM. |
| PTCT - PTC Therapeutics Inc | BUY | 418 @ USD 74.68 | USD 31,216 | The ETF bought 418 new shares of PTCT (PTC Therapeutics Inc). The shares were bought for an average price of 74.68 compared to the previous average buy price of 61.3082. This is 21.8% higher than average price of previous purchases of PTCT. |
| IPN.PA - Ipsen SA | BUY | 191 @ EUR 160.863 | EUR 30,725 | The ETF bought 191 new shares of IPN.PA (Ipsen SA). The shares were bought for an average price of 160.863 compared to the previous average buy price of 128.01. This is 25.7% higher than average price of previous purchases of IPN.PA. |
| ALKS - Alkermes Plc | BUY | 874 @ USD 34.91 | USD 30,511 | The ETF bought 874 new shares of ALKS (Alkermes Plc). The shares were bought for an average price of 34.91 compared to the previous average buy price of 30.3174. This is 15.1% higher than average price of previous purchases of ALKS. |
| BIM.PA - BioMerieux | BUY | 257 @ EUR 112.049 | EUR 28,797 | The ETF bought 257 new shares of BIM.PA (BioMerieux). The shares were bought for an average price of 112.049 compared to the previous average buy price of 123.369. This is -9.2% lower than average price of previous purchases of BIM.PA. |
| SFZN.SW - | BUY | 208 @ CHF 124.218 | CHF 25,837 | The ETF bought 208 new shares of SFZN.SW (). The shares were bought for an average price of 124.218 compared to the previous average buy price of 123.113. This is 0.9% higher than average price of previous purchases of SFZN.SW. |
| 6869.T - Sysmex Corporation | BUY | 2,700 @ JPY 9.52791 | JPY 25,725 | The ETF bought 2700 new shares of 6869.T (Sysmex Corporation). The shares were bought for an average price of 9.52791 compared to the previous average buy price of 13.9292. This is -31.6% lower than average price of previous purchases of 6869.T. |
| LNTH - Lantheus Holdings Inc | BUY | 362 @ USD 64.89 | USD 23,490 | The ETF bought 362 new shares of LNTH (Lantheus Holdings Inc). The shares were bought for an average price of 64.89 compared to the previous average buy price of 75.2336. This is -13.7% lower than average price of previous purchases of LNTH. |
| 298380.KQ - ABL Bio Inc. | BUY | 189 @ KRW 120.862 | KRW 22,843 | The ETF bought 189 new shares of 298380.KQ (ABL Bio Inc.). The shares were bought for an average price of 120.862 compared to the previous average buy price of 108.523. This is 11.4% higher than average price of previous purchases of 298380.KQ. |
| MMS - LYXETFETUSITETFP | BUY | 297 @ USD 75.08 | USD 22,299 | The ETF bought 297 new shares of MMS (LYXETFETUSITETFP). The shares were bought for an average price of 75.08 compared to the previous average buy price of 79.4418. This is -5.5% lower than average price of previous purchases of MMS. |
| TGTX - TG Therapeutics Inc | BUY | 762 @ USD 28.86 | USD 21,991 | The ETF bought 762 new shares of TGTX (TG Therapeutics Inc). The shares were bought for an average price of 28.86 compared to the previous average buy price of 32.8137. This is -12.0% lower than average price of previous purchases of TGTX. |
| 7747.T - Asahi Intecc Co., Ltd. | BUY | 1,300 @ JPY 16.1359 | JPY 20,977 | The ETF bought 1300 new shares of 7747.T (Asahi Intecc Co., Ltd.). The shares were bought for an average price of 16.1359 compared to the previous average buy price of 17.2752. This is -6.6% lower than average price of previous purchases of 7747.T. |
| LGND - Ligand Pharmaceuticals Incorporated | BUY | 101 @ USD 190.44 | USD 19,234 | The ETF bought 101 new shares of LGND (Ligand Pharmaceuticals Incorporated). The shares were bought for an average price of 190.44 compared to the previous average buy price of 133.982. This is 42.1% higher than average price of previous purchases of LGND. |
| LIVN - LivaNova PLC | BUY | 288 @ USD 66.56 | USD 19,169 | The ETF bought 288 new shares of LIVN (LivaNova PLC). The shares were bought for an average price of 66.56 compared to the previous average buy price of 53.1592. This is 25.2% higher than average price of previous purchases of LIVN. |
| SECT-B.ST - | BUY | 769 @ SEK 23.1246 | SEK 17,783 | The ETF bought 769 new shares of SECT-B.ST (). The shares were bought for an average price of 23.1246 compared to the previous average buy price of 27.5618. This is -16.1% lower than average price of previous purchases of SECT-B.ST. |
| CGON - CG Oncology, Inc. Common stock | BUY | 324 @ USD 50.36 | USD 16,317 | The ETF bought 324 new shares of CGON (CG Oncology, Inc. Common stock). The shares were bought for an average price of 50.36 compared to the previous average buy price of 43.3614. This is 16.1% higher than average price of previous purchases of CGON. |
| CPRX - Catalyst Pharmaceuticals Inc | BUY | 645 @ USD 24.44 | USD 15,764 | The ETF bought 645 new shares of CPRX (Catalyst Pharmaceuticals Inc). The shares were bought for an average price of 24.44 compared to the previous average buy price of 22.5395. This is 8.4% higher than average price of previous purchases of CPRX. |
| SUPN - Supernus Pharmaceuticals Inc | BUY | 298 @ USD 51.65 | USD 15,392 | The ETF bought 298 new shares of SUPN (Supernus Pharmaceuticals Inc). The shares were bought for an average price of 51.65 compared to the previous average buy price of 40.6241. This is 27.1% higher than average price of previous purchases of SUPN. |
| ACAD - ACADIA Pharmaceuticals Inc | BUY | 651 @ USD 23.56 | USD 15,338 | The ETF bought 651 new shares of ACAD (ACADIA Pharmaceuticals Inc). The shares were bought for an average price of 23.56 compared to the previous average buy price of 21.2784. This is 10.7% higher than average price of previous purchases of ACAD. |
| ACLX - Arcellx Inc | BUY | 220 @ USD 68.03 | USD 14,967 | The ETF bought 220 new shares of ACLX (Arcellx Inc). The shares were bought for an average price of 68.03 compared to the previous average buy price of 65.004. This is 4.7% higher than average price of previous purchases of ACLX. |
| IDYA - Ideaya Biosciences Inc | BUY | 462 @ USD 32.17 | USD 14,863 | The ETF bought 462 new shares of IDYA (Ideaya Biosciences Inc). The shares were bought for an average price of 32.17 compared to the previous average buy price of 24.8278. This is 29.6% higher than average price of previous purchases of IDYA. |
| TWST - Twist Bioscience Corp | BUY | 295 @ USD 49.24 | USD 14,526 | The ETF bought 295 new shares of TWST (Twist Bioscience Corp). The shares were bought for an average price of 49.24 compared to the previous average buy price of 36.5506. This is 34.7% higher than average price of previous purchases of TWST. |
| BANB.SW - | BUY | 168 @ CHF 86.2947 | CHF 14,498 | The ETF bought 168 new shares of BANB.SW (). The shares were bought for an average price of 86.2947 compared to the previous average buy price of 70.3497. This is 22.7% higher than average price of previous purchases of BANB.SW. |
| BEAM - Beam Therapeutics Inc | BUY | 534 @ USD 26.52 | USD 14,162 | The ETF bought 534 new shares of BEAM (Beam Therapeutics Inc). The shares were bought for an average price of 26.52 compared to the previous average buy price of 19.259. This is 37.7% higher than average price of previous purchases of BEAM. |
| VCYT - Veracyte Inc | BUY | 385 @ USD 36.19 | USD 13,933 | The ETF bought 385 new shares of VCYT (Veracyte Inc). The shares were bought for an average price of 36.19 compared to the previous average buy price of 36.6113. This is -1.2% lower than average price of previous purchases of VCYT. |
| VRDN - Viridian Therapeutics Inc | BUY | 436 @ USD 29.25 | USD 12,753 | The ETF bought 436 new shares of VRDN (Viridian Therapeutics Inc). The shares were bought for an average price of 29.25 compared to the previous average buy price of 30.5932. This is -4.4% lower than average price of previous purchases of VRDN. |
| BAVA.CO - | BUY | 413 @ DKK 30.6078 | DKK 12,641 | The ETF bought 413 new shares of BAVA.CO (). The shares were bought for an average price of 30.6078 compared to the previous average buy price of 26.2839. This is 16.5% higher than average price of previous purchases of BAVA.CO. |
| ADPT - Adaptive Biotechnologies Corp | BUY | 796 @ USD 15.77 | USD 12,553 | The ETF bought 796 new shares of ADPT (Adaptive Biotechnologies Corp). The shares were bought for an average price of 15.77 compared to the previous average buy price of 7.61991. This is 107.0% higher than average price of previous purchases of ADPT. |
| NEOG - Neogen Corporation | BUY | 1,126 @ USD 10.8 | USD 12,161 | The ETF bought 1126 new shares of NEOG (Neogen Corporation). The shares were bought for an average price of 10.8 compared to the previous average buy price of 9.65556. This is 11.9% higher than average price of previous purchases of NEOG. |
| DIA.MI - DiaSorin SpA | BUY | 140 @ EUR 86.8497 | EUR 12,159 | The ETF bought 140 new shares of DIA.MI (DiaSorin SpA). The shares were bought for an average price of 86.8497 compared to the previous average buy price of 64.1129. This is 35.5% higher than average price of previous purchases of DIA.MI. |
| EKTA-B.ST - | BUY | 1,951 @ SEK 6.14143 | SEK 11,982 | The ETF bought 1951 new shares of EKTA-B.ST (). The shares were bought for an average price of 6.14143 compared to the previous average buy price of 5.82449. This is 5.4% higher than average price of previous purchases of EKTA-B.ST. |
| TECN.SW - | BUY | 67 @ CHF 175.814 | CHF 11,780 | The ETF bought 67 new shares of TECN.SW (). The shares were bought for an average price of 175.814 compared to the previous average buy price of 191.509. This is -8.2% lower than average price of previous purchases of TECN.SW. |
| 6951.T - JEOL Ltd. | BUY | 300 @ JPY 39.1763 | JPY 11,753 | The ETF bought 300 new shares of 6951.T (JEOL Ltd.). The shares were bought for an average price of 39.1763 compared to the previous average buy price of 33.4591. This is 17.1% higher than average price of previous purchases of 6951.T. |
| TXG - 10X Genomics Inc | BUY | 596 @ USD 18.61 | USD 11,092 | The ETF bought 596 new shares of TXG (10X Genomics Inc). The shares were bought for an average price of 18.61 compared to the previous average buy price of 14.1607. This is 31.4% higher than average price of previous purchases of TXG. |
| TXG - Terex Corporation | BUY | 596 @ USD 18.61 | USD 11,092 | The ETF bought 596 new shares of TXG (Terex Corporation). The shares were bought for an average price of 18.61 compared to the previous average buy price of 14.1607. This is 31.4% higher than average price of previous purchases of TXG. |
| 326030.KS - SK BIOPHARMACEUTICALS LTD | BUY | 147 @ KRW 73.8372 | KRW 10,854 | The ETF bought 147 new shares of 326030.KS (SK BIOPHARMACEUTICALS LTD). The shares were bought for an average price of 73.8372 compared to the previous average buy price of 79.2638. This is -6.8% lower than average price of previous purchases of 326030.KS. |
| QDEL - Quidel Corporation | BUY | 362 @ USD 29.1 | USD 10,534 | The ETF bought 362 new shares of QDEL (Quidel Corporation). The shares were bought for an average price of 29.1 compared to the previous average buy price of 29.5597. This is -1.6% lower than average price of previous purchases of QDEL. |
| 9995.HK - REMEGEN LTD H | BUY | 1,000 @ HKD 10.0706 | HKD 10,071 | The ETF bought 1000 new shares of 9995.HK (REMEGEN LTD H). The shares were bought for an average price of 10.0706 compared to the previous average buy price of 10.1181. This is -0.5% lower than average price of previous purchases of 9995.HK. |
| 3933.HK - THE UNITED LABORATORIES INTERNATIO | BUY | 6,000 @ HKD 1.67375 | HKD 10,043 | The ETF bought 6000 new shares of 3933.HK (THE UNITED LABORATORIES INTERNATIO). The shares were bought for an average price of 1.67375 compared to the previous average buy price of 1.6406. This is 2.0% higher than average price of previous purchases of 3933.HK. |
| AUPH - Aurinia Pharmaceuticals Inc | BUY | 694 @ USD 14.44 | USD 10,021 | The ETF bought 694 new shares of AUPH (Aurinia Pharmaceuticals Inc). The shares were bought for an average price of 14.44 compared to the previous average buy price of 12.7166. This is 13.6% higher than average price of previous purchases of AUPH. |
| DVAX - Dynavax Technologies Corporation | BUY | 644 @ USD 15.5 | USD 9,982 | The ETF bought 644 new shares of DVAX (Dynavax Technologies Corporation). The shares were bought for an average price of 15.5 compared to the previous average buy price of 13.8172. This is 12.2% higher than average price of previous purchases of DVAX. |
| KNSA - Kiniksa Pharmaceuticals Ltd | BUY | 227 @ USD 43.09 | USD 9,781 | The ETF bought 227 new shares of KNSA (Kiniksa Pharmaceuticals Ltd). The shares were bought for an average price of 43.09 compared to the previous average buy price of 40.7465. This is 5.8% higher than average price of previous purchases of KNSA. |
| SRPT - Sarepta Therapeutics Inc | BUY | 525 @ USD 18.5 | USD 9,713 | The ETF bought 525 new shares of SRPT (Sarepta Therapeutics Inc). The shares were bought for an average price of 18.5 compared to the previous average buy price of 41.9008. This is -55.8% lower than average price of previous purchases of SRPT. |
| ATRC - AtriCure Inc | BUY | 259 @ USD 37.11 | USD 9,611 | The ETF bought 259 new shares of ATRC (AtriCure Inc). The shares were bought for an average price of 37.11 compared to the previous average buy price of 34.5694. This is 7.3% higher than average price of previous purchases of ATRC. |
| STOK - Stoke Therapeutics Inc | BUY | 294 @ USD 32.4 | USD 9,526 | The ETF bought 294 new shares of STOK (Stoke Therapeutics Inc). The shares were bought for an average price of 32.4 compared to the previous average buy price of 14.0152. This is 131.2% higher than average price of previous purchases of STOK. |
| 13.HK - HUTCHMED (CHINA) LTD | BUY | 3,000 @ HKD 2.99176 | HKD 8,975 | The ETF bought 3000 new shares of 13.HK (HUTCHMED (CHINA) LTD). The shares were bought for an average price of 2.99176 compared to the previous average buy price of 2.99975. This is -0.3% lower than average price of previous purchases of 13.HK. |
| HRMY - Harmony Biosciences Holdings | BUY | 240 @ USD 37.27 | USD 8,945 | The ETF bought 240 new shares of HRMY (Harmony Biosciences Holdings). The shares were bought for an average price of 37.27 compared to the previous average buy price of 33.9009. This is 9.9% higher than average price of previous purchases of HRMY. |
| HLUN-B.CO - | BUY | 1,470 @ DKK 5.92848 | DKK 8,715 | The ETF bought 1470 new shares of HLUN-B.CO (). The shares were bought for an average price of 5.92848 compared to the previous average buy price of 6.33828. This is -6.5% lower than average price of previous purchases of HLUN-B.CO. |
| RXRX - Recursion Pharmaceuticals Inc | BUY | 2,154 @ USD 3.98 | USD 8,573 | The ETF bought 2154 new shares of RXRX (Recursion Pharmaceuticals Inc). The shares were bought for an average price of 3.98 compared to the previous average buy price of 5.07031. This is -21.5% lower than average price of previous purchases of RXRX. |
| RCUS - Arcus Biosciences Inc | BUY | 401 @ USD 21.03 | USD 8,433 | The ETF bought 401 new shares of RCUS (Arcus Biosciences Inc). The shares were bought for an average price of 21.03 compared to the previous average buy price of 10.6985. This is 96.6% higher than average price of previous purchases of RCUS. |
| AXGN - Axogen Inc | BUY | 231 @ USD 34.93 | USD 8,069 | The ETF bought 231 new shares of AXGN (Axogen Inc). The shares were bought for an average price of 34.93 compared to the previous average buy price of 20.2186. This is 72.8% higher than average price of previous purchases of AXGN. |
| CRVL - CorVel Corp | BUY | 155 @ USD 48.67 | USD 7,544 | The ETF bought 155 new shares of CRVL (CorVel Corp). The shares were bought for an average price of 48.67 compared to the previous average buy price of 110.425. This is -55.9% lower than average price of previous purchases of CRVL. |
| 4887.T - Sawai Group Holdings Co., Ltd. | BUY | 500 @ JPY 15.0617 | JPY 7,531 | The ETF bought 500 new shares of 4887.T (Sawai Group Holdings Co., Ltd.). The shares were bought for an average price of 15.0617 compared to the previous average buy price of 13.8148. This is 9.0% higher than average price of previous purchases of 4887.T. |
| NUVB - Nuvation Bio Inc | BUY | 1,319 @ USD 5.7 | USD 7,518 | The ETF bought 1319 new shares of NUVB (Nuvation Bio Inc). The shares were bought for an average price of 5.7 compared to the previous average buy price of 7.81193. This is -27.0% lower than average price of previous purchases of NUVB. |
| BIOA-B.ST - | BUY | 215 @ SEK 34.0107 | SEK 7,312 | The ETF bought 215 new shares of BIOA-B.ST (). The shares were bought for an average price of 34.0107 compared to the previous average buy price of 30.8459. This is 10.3% higher than average price of previous purchases of BIOA-B.ST. |
| IBRX - Immunitybio Inc | BUY | 1,206 @ USD 6.05 | USD 7,296 | The ETF bought 1206 new shares of IBRX (Immunitybio Inc). The shares were bought for an average price of 6.05 compared to the previous average buy price of 2.8933. This is 109.1% higher than average price of previous purchases of IBRX. |
| BCRX - BioCryst Pharmaceuticals Inc | BUY | 1,129 @ USD 6.38 | USD 7,203 | The ETF bought 1129 new shares of BCRX (BioCryst Pharmaceuticals Inc). The shares were bought for an average price of 6.38 compared to the previous average buy price of 7.69136. This is -17.0% lower than average price of previous purchases of BCRX. |
| FTRE - Fortrea Holdings Inc. | BUY | 486 @ USD 14.65 | USD 7,120 | The ETF bought 486 new shares of FTRE (Fortrea Holdings Inc.). The shares were bought for an average price of 14.65 compared to the previous average buy price of 11.759. This is 24.6% higher than average price of previous purchases of FTRE. |
| 2162.HK - KEYMED BIOSCIENCES INC | BUY | 1,000 @ HKD 7.02513 | HKD 7,025 | The ETF bought 1000 new shares of 2162.HK (KEYMED BIOSCIENCES INC). The shares were bought for an average price of 7.02513 compared to the previous average buy price of 5.51394. This is 27.4% higher than average price of previous purchases of 2162.HK. |
| RLAY - Relay Therapeutics Inc | BUY | 785 @ USD 8.92 | USD 7,002 | The ETF bought 785 new shares of RLAY (Relay Therapeutics Inc). The shares were bought for an average price of 8.92 compared to the previous average buy price of 7.15494. This is 24.7% higher than average price of previous purchases of RLAY. |
| TNDM - Tandem Diabetes Care Inc | BUY | 361 @ USD 19.17 | USD 6,920 | The ETF bought 361 new shares of TNDM (Tandem Diabetes Care Inc). The shares were bought for an average price of 19.17 compared to the previous average buy price of 21.211. This is -9.6% lower than average price of previous purchases of TNDM. |
| 237690.KQ - ST Pharm Co.,Ltd. | BUY | 69 @ KRW 99.8333 | KRW 6,888 | The ETF bought 69 new shares of 237690.KQ (ST Pharm Co.,Ltd.). The shares were bought for an average price of 99.8333 compared to the previous average buy price of 62.1333. This is 60.7% higher than average price of previous purchases of 237690.KQ. |
| GLPG.AS - Galapagos NV | BUY | 199 @ EUR 33.3073 | EUR 6,628 | The ETF bought 199 new shares of GLPG.AS (Galapagos NV). The shares were bought for an average price of 33.3073 compared to the previous average buy price of 30.5298. This is 9.1% higher than average price of previous purchases of GLPG.AS. |
| NVAX - Novavax Inc | BUY | 794 @ USD 8.25 | USD 6,551 | The ETF bought 794 new shares of NVAX (Novavax Inc). The shares were bought for an average price of 8.25 compared to the previous average buy price of 6.61187. This is 24.8% higher than average price of previous purchases of NVAX. |
| NVAX - Hana Microelectronics Public Company Limited | BUY | 794 @ USD 8.25 | USD 6,551 | The ETF bought 794 new shares of NVAX (Hana Microelectronics Public Company Limited). The shares were bought for an average price of 8.25 compared to the previous average buy price of 6.61187. This is 24.8% higher than average price of previous purchases of NVAX. |
| 2252.HK - SHANGHAI MICROPORT MEDBOT CLASS H | BUY | 2,000 @ HKD 3.21953 | HKD 6,439 | The ETF bought 2000 new shares of 2252.HK (SHANGHAI MICROPORT MEDBOT CLASS H). The shares were bought for an average price of 3.21953 compared to the previous average buy price of 3.21365. This is 0.2% higher than average price of previous purchases of 2252.HK. |
| PHM.MC - Pharma Mar SA | BUY | 71 @ EUR 90.1237 | EUR 6,399 | The ETF bought 71 new shares of PHM.MC (Pharma Mar SA). The shares were bought for an average price of 90.1237 compared to the previous average buy price of 88.2649. This is 2.1% higher than average price of previous purchases of PHM.MC. |
| CHEMM.CO - | BUY | 92 @ DKK 68.369 | DKK 6,290 | The ETF bought 92 new shares of CHEMM.CO (). The shares were bought for an average price of 68.369 compared to the previous average buy price of 82.8448. This is -17.5% lower than average price of previous purchases of CHEMM.CO. |
| 039200.KQ - Oscotec Inc. | BUY | 176 @ KRW 35.5916 | KRW 6,264 | The ETF bought 176 new shares of 039200.KQ (Oscotec Inc.). The shares were bought for an average price of 35.5916 compared to the previous average buy price of 21.7161. This is 63.9% higher than average price of previous purchases of 039200.KQ. |
| ZYME - Zymeworks Inc. Common Stock | BUY | 269 @ USD 22.72 | USD 6,112 | The ETF bought 269 new shares of ZYME (Zymeworks Inc. Common Stock). The shares were bought for an average price of 22.72 compared to the previous average buy price of 19.9916. This is 13.6% higher than average price of previous purchases of ZYME. |
| NEU.AX - | BUY | 686 @ AUD 8.77214 | AUD 6,018 | The ETF bought 686 new shares of NEU.AX (). The shares were bought for an average price of 8.77214 compared to the previous average buy price of 9.32504. This is -5.9% lower than average price of previous purchases of NEU.AX. |
| PHARM.AS - Pharming Group NV | BUY | 3,672 @ EUR 1.61454 | EUR 5,929 | The ETF bought 3672 new shares of PHARM.AS (Pharming Group NV). The shares were bought for an average price of 1.61454 compared to the previous average buy price of 1.013. This is 59.4% higher than average price of previous purchases of PHARM.AS. |
| DYVOX.ST - | BUY | 573 @ SEK 10.2265 | SEK 5,860 | The ETF bought 573 new shares of DYVOX.ST (). The shares were bought for an average price of 10.2265 compared to the previous average buy price of 7.64532. This is 33.8% higher than average price of previous purchases of DYVOX.ST. |
| ONT.L - Oxford Nanopore Technologies Ltd | BUY | 3,021 @ GBP 1.91957 | GBP 5,799 | The ETF bought 3021 new shares of ONT.L (Oxford Nanopore Technologies Ltd). The shares were bought for an average price of 1.91957 compared to the previous average buy price of 1.81535. This is 5.7% higher than average price of previous purchases of ONT.L. |
| EVT.DE - Evotec SE | BUY | 791 @ EUR 7.26663 | EUR 5,748 | The ETF bought 791 new shares of EVT.DE (Evotec SE). The shares were bought for an average price of 7.26663 compared to the previous average buy price of 6.65945. This is 9.1% higher than average price of previous purchases of EVT.DE. |
| ANAB - AnaptysBio Inc | BUY | 113 @ USD 49.73 | USD 5,619 | The ETF bought 113 new shares of ANAB (AnaptysBio Inc). The shares were bought for an average price of 49.73 compared to the previous average buy price of 25.5396. This is 94.7% higher than average price of previous purchases of ANAB. |
| NVCR - Novocure Ltd | BUY | 553 @ USD 10.14 | USD 5,607 | The ETF bought 553 new shares of NVCR (Novocure Ltd). The shares were bought for an average price of 10.14 compared to the previous average buy price of 15.9386. This is -36.4% lower than average price of previous purchases of NVCR. |
| BLFS - BioLife Solutions Inc | BUY | 247 @ USD 22.43 | USD 5,540 | The ETF bought 247 new shares of BLFS (BioLife Solutions Inc). The shares were bought for an average price of 22.43 compared to the previous average buy price of 25.3348. This is -11.5% lower than average price of previous purchases of BLFS. |
| AMLX - Amylyx Pharmaceuticals Inc | BUY | 389 @ USD 13.98 | USD 5,438 | The ETF bought 389 new shares of AMLX (Amylyx Pharmaceuticals Inc). The shares were bought for an average price of 13.98 compared to the previous average buy price of 13.5867. This is 2.9% higher than average price of previous purchases of AMLX. |
| CDNA - Caredx Inc | BUY | 271 @ USD 19.47 | USD 5,276 | The ETF bought 271 new shares of CDNA (Caredx Inc). The shares were bought for an average price of 19.47 compared to the previous average buy price of 19.2653. This is 1.1% higher than average price of previous purchases of CDNA. |
| ARVN - Arvinas Inc | BUY | 372 @ USD 13.48 | USD 5,015 | The ETF bought 372 new shares of ARVN (Arvinas Inc). The shares were bought for an average price of 13.48 compared to the previous average buy price of 11.4578. This is 17.6% higher than average price of previous purchases of ARVN. |
| CSTL - Castle Biosciences Inc | BUY | 152 @ USD 32.75 | USD 4,978 | The ETF bought 152 new shares of CSTL (Castle Biosciences Inc). The shares were bought for an average price of 32.75 compared to the previous average buy price of 23.8365. This is 37.4% higher than average price of previous purchases of CSTL. |
| 4587.T - PeptiDream Inc. | BUY | 500 @ JPY 9.66817 | JPY 4,834 | The ETF bought 500 new shares of 4587.T (PeptiDream Inc.). The shares were bought for an average price of 9.66817 compared to the previous average buy price of 10.975. This is -11.9% lower than average price of previous purchases of 4587.T. |
| DAWN - Day One Biopharmaceuticals Inc | BUY | 404 @ USD 11.41 | USD 4,610 | The ETF bought 404 new shares of DAWN (Day One Biopharmaceuticals Inc). The shares were bought for an average price of 11.41 compared to the previous average buy price of 9.52558. This is 19.8% higher than average price of previous purchases of DAWN. |
| 302440.KS - SK BIOSCIENCE LTD | BUY | 137 @ KRW 33.2778 | KRW 4,559 | The ETF bought 137 new shares of 302440.KS (SK BIOSCIENCE LTD). The shares were bought for an average price of 33.2778 compared to the previous average buy price of 35.7815. This is -7.0% lower than average price of previous purchases of 302440.KS. |
| ASTH - Astrana Health Inc | BUY | 213 @ USD 21.1 | USD 4,494 | The ETF bought 213 new shares of ASTH (Astrana Health Inc). The shares were bought for an average price of 21.1 compared to the previous average buy price of 26.6318. This is -20.8% lower than average price of previous purchases of ASTH. |
| CERT - Certara Inc | BUY | 616 @ USD 7.23 | USD 4,454 | The ETF bought 616 new shares of CERT (Certara Inc). The shares were bought for an average price of 7.23 compared to the previous average buy price of 10.2768. This is -29.6% lower than average price of previous purchases of CERT. |
| SDGR - Schrodinger Inc | BUY | 327 @ USD 13.49 | USD 4,411 | The ETF bought 327 new shares of SDGR (Schrodinger Inc). The shares were bought for an average price of 13.49 compared to the previous average buy price of 20.2044. This is -33.2% lower than average price of previous purchases of SDGR. |
| IART - Integra LifeSciences Holdings | BUY | 385 @ USD 11.26 | USD 4,335 | The ETF bought 385 new shares of IART (Integra LifeSciences Holdings). The shares were bought for an average price of 11.26 compared to the previous average buy price of 15.5324. This is -27.5% lower than average price of previous purchases of IART. |
| 007390.KQ - NatureCell Co.,Ltd. | BUY | 278 @ KRW 15.516 | KRW 4,313 | The ETF bought 278 new shares of 007390.KQ (NatureCell Co.,Ltd.). The shares were bought for an average price of 15.516 compared to the previous average buy price of 21.1396. This is -26.6% lower than average price of previous purchases of 007390.KQ. |
| EUZ.DE - Eckert & Ziegler SE | BUY | 228 @ EUR 18.2493 | EUR 4,161 | The ETF bought 228 new shares of EUZ.DE (Eckert & Ziegler SE). The shares were bought for an average price of 18.2493 compared to the previous average buy price of 18.5221. This is -1.5% lower than average price of previous purchases of EUZ.DE. |
| JANX - Janux Therapeutics Inc | BUY | 304 @ USD 13.07 | USD 3,973 | The ETF bought 304 new shares of JANX (Janux Therapeutics Inc). The shares were bought for an average price of 13.07 compared to the previous average buy price of 24.2014. This is -46.0% lower than average price of previous purchases of JANX. |
| 328130.KQ - Lunit Inc. | BUY | 142 @ KRW 27.3912 | KRW 3,890 | The ETF bought 142 new shares of 328130.KQ (Lunit Inc.). The shares were bought for an average price of 27.3912 compared to the previous average buy price of 35.4304. This is -22.7% lower than average price of previous purchases of 328130.KQ. |
| VIR - Vir Biotechnology Inc | BUY | 539 @ USD 7.19 | USD 3,875 | The ETF bought 539 new shares of VIR (Vir Biotechnology Inc). The shares were bought for an average price of 7.19 compared to the previous average buy price of 6.97311. This is 3.1% higher than average price of previous purchases of VIR. |
| VIR - Vidrala S.A | BUY | 539 @ USD 7.19 | USD 3,875 | The ETF bought 539 new shares of VIR (Vidrala S.A). The shares were bought for an average price of 7.19 compared to the previous average buy price of 6.97311. This is 3.1% higher than average price of previous purchases of VIR. |
| ABCL - Abcellera Biologics Inc | BUY | 1,220 @ USD 3.16 | USD 3,855 | The ETF bought 1220 new shares of ABCL (Abcellera Biologics Inc). The shares were bought for an average price of 3.16 compared to the previous average buy price of 3.67532. This is -14.0% lower than average price of previous purchases of ABCL. |
| RO.SW - | BUY | 8 @ CHF 470.558 | CHF 3,764 | The ETF bought 8 new shares of RO.SW (). The shares were bought for an average price of 470.558 compared to the previous average buy price of 378.413. This is 24.4% higher than average price of previous purchases of RO.SW. |
| IOVA - Iovance Biotherapeutics Inc | BUY | 1,474 @ USD 2.53 | USD 3,729 | The ETF bought 1474 new shares of IOVA (Iovance Biotherapeutics Inc). The shares were bought for an average price of 2.53 compared to the previous average buy price of 2.43152. This is 4.1% higher than average price of previous purchases of IOVA. |
| VLA.PA - Valneva SE | BUY | 728 @ EUR 4.7609 | EUR 3,466 | The ETF bought 728 new shares of VLA.PA (Valneva SE). The shares were bought for an average price of 4.7609 compared to the previous average buy price of 3.01716. This is 57.8% higher than average price of previous purchases of VLA.PA. |
| 096530.KQ - Seegene, Inc. | BUY | 192 @ KRW 17.5916 | KRW 3,378 | The ETF bought 192 new shares of 096530.KQ (Seegene, Inc.). The shares were bought for an average price of 17.5916 compared to the previous average buy price of 17.2899. This is 1.7% higher than average price of previous purchases of 096530.KQ. |
| EMBC - Embecta Corp | BUY | 307 @ USD 10.865 | USD 3,336 | The ETF bought 307 new shares of EMBC (Embecta Corp). The shares were bought for an average price of 10.865 compared to the previous average buy price of 12.4848. This is -13.0% lower than average price of previous purchases of EMBC. |
| KURA - Kura Oncology Inc | BUY | 417 @ USD 7.83 | USD 3,265 | The ETF bought 417 new shares of KURA (Kura Oncology Inc). The shares were bought for an average price of 7.83 compared to the previous average buy price of 10.0287. This is -21.9% lower than average price of previous purchases of KURA. |
| CTKB - Cytek Biosciences Inc | BUY | 698 @ USD 4.47 | USD 3,120 | The ETF bought 698 new shares of CTKB (Cytek Biosciences Inc). The shares were bought for an average price of 4.47 compared to the previous average buy price of 5.65349. This is -20.9% lower than average price of previous purchases of CTKB. |
| PACB - Pacific Biosciences of California | BUY | 1,607 @ USD 1.82 | USD 2,925 | The ETF bought 1607 new shares of PACB (Pacific Biosciences of California). The shares were bought for an average price of 1.82 compared to the previous average buy price of 1.46365. This is 24.3% higher than average price of previous purchases of PACB. |
| XVIVO.ST - | BUY | 131 @ SEK 22.2821 | SEK 2,919 | The ETF bought 131 new shares of XVIVO.ST (). The shares were bought for an average price of 22.2821 compared to the previous average buy price of 37.4926. This is -40.6% lower than average price of previous purchases of XVIVO.ST. |
| 7575.T - Japan Lifeline Co., Ltd. | BUY | 300 @ JPY 8.91269 | JPY 2,674 | The ETF bought 300 new shares of 7575.T (Japan Lifeline Co., Ltd.). The shares were bought for an average price of 8.91269 compared to the previous average buy price of 10.1599. This is -12.3% lower than average price of previous purchases of 7575.T. |
| MYGN - Myriad Genetics Inc | BUY | 488 @ USD 5.12 | USD 2,499 | The ETF bought 488 new shares of MYGN (Myriad Genetics Inc). The shares were bought for an average price of 5.12 compared to the previous average buy price of 8.2372. This is -37.8% lower than average price of previous purchases of MYGN. |
| RGNX - Regenxbio Inc | BUY | 238 @ USD 10.33 | USD 2,459 | The ETF bought 238 new shares of RGNX (Regenxbio Inc). The shares were bought for an average price of 10.33 compared to the previous average buy price of 9.29232. This is 11.2% higher than average price of previous purchases of RGNX. |
| LAB - Standard Biotools Inc | BUY | 1,858 @ USD 1.26 | USD 2,341 | The ETF bought 1858 new shares of LAB (Standard Biotools Inc). The shares were bought for an average price of 1.26 compared to the previous average buy price of 1.38379. This is -8.9% lower than average price of previous purchases of LAB. |
| VNDA - Vanda Pharmaceuticals Inc | BUY | 303 @ USD 7.57 | USD 2,294 | The ETF bought 303 new shares of VNDA (Vanda Pharmaceuticals Inc). The shares were bought for an average price of 7.57 compared to the previous average buy price of 5.79906. This is 30.5% higher than average price of previous purchases of VNDA. |
| MRVI - Maravai Lifesciences Holdings Inc | BUY | 703 @ USD 3.14 | USD 2,207 | The ETF bought 703 new shares of MRVI (Maravai Lifesciences Holdings Inc). The shares were bought for an average price of 3.14 compared to the previous average buy price of 3.04161. This is 3.2% higher than average price of previous purchases of MRVI. |
| 1877.HK - SHANGHAI JUNSHI BIOSCIENCES LTD H | BUY | 800 @ HKD 2.66162 | HKD 2,129 | The ETF bought 800 new shares of 1877.HK (SHANGHAI JUNSHI BIOSCIENCES LTD H). The shares were bought for an average price of 2.66162 compared to the previous average buy price of 2.67899. This is -0.6% lower than average price of previous purchases of 1877.HK. |
| EVH - Evolent Health Inc | BUY | 576 @ USD 2.85 | USD 1,642 | The ETF bought 576 new shares of EVH (Evolent Health Inc). The shares were bought for an average price of 2.85 compared to the previous average buy price of 8.43957. This is -66.2% lower than average price of previous purchases of EVH. |
| 4549.T - Eiken Chemical Co., Ltd. | BUY | 100 @ JPY 15.7088 | JPY 1,571 | The ETF bought 100 new shares of 4549.T (Eiken Chemical Co., Ltd.). The shares were bought for an average price of 15.7088 compared to the previous average buy price of 13.8284. This is 13.6% higher than average price of previous purchases of 4549.T. |
| SLP - Sylvania Platinum Limited | BUY | 83 @ USD 14.57 | USD 1,209 | The ETF bought 83 new shares of SLP (Sylvania Platinum Limited). The shares were bought for an average price of 14.57 compared to the previous average buy price of 25.4848. This is -42.8% lower than average price of previous purchases of SLP. |
| 4974.T - Takara Bio Inc. | BUY | 200 @ JPY 5.08113 | JPY 1,016 | The ETF bought 200 new shares of 4974.T (Takara Bio Inc.). The shares were bought for an average price of 5.08113 compared to the previous average buy price of 5.60044. This is -9.3% lower than average price of previous purchases of 4974.T. |
| ARCT - Arcturus Therapeutics Holdings Inc | BUY | 123 @ USD 7.57001 | USD 931 | The ETF bought 123 new shares of ARCT (Arcturus Therapeutics Holdings Inc). The shares were bought for an average price of 7.57001 compared to the previous average buy price of 10.8202. This is -30.0% lower than average price of previous purchases of ARCT. |
| - - | HOLD | 0 @ USD 0 | USD 0 | The current share valuation price of - based on adjusted close was USD 0. The average price that - shares were previous bought at was USD 0.00279608. The current market price is -100.0% lower than average price they were purchased at. USD 0 compared to the previous valuation of however if the holding was sold on 2026-02-06 this would crystalise an overall loss. |